Clinical characteristics and impact of glycemic control and antifungal treatment on mortality in patients with Rhino-Orbital Mucormycosis in Mexico: A retrospective cohort study

BackgroundRhino-orbital mucormycosis (ROM) is an invasive fungal infection with a high mortality rate, particularly in patients with metabolic and immunological disorders. Despite advancements in diagnosis and treatment, mortality remains significant, emphasizing the need to identify prognostic factors associated with poor outcomes. ObjectivesThis study aimed to analyze risk factors associated with mortality in patients with ROM, with a specific focus on the impact of glycemic control, diabetic ketoacidosis (DKA), and the type of surgical approach. MethodsA retrospective cohort study was conducted at a tertiary care hospital in Mexico, including 40 adult patients diagnosed with ROM between January 2019 and June 2023. Clinical, laboratory, and therapeutic variables were analyzed. Logistic regression and Kaplan-Meier survival analysis were performed to identify independent predictors of mortality. ResultsThe overall mortality rate was 42.5%. Uncontrolled diabetes was the strongest predictor of mortality (OR 45.33, 95% CI 4.90-419.22, p <0.001). DKA was also significantly associated with increased mortality (RR 3.09, 95% CI 1.90-5.02, p= 0.003). Neutrophilia ([&ge;]7,500/{micro}L) was linked to a higher risk of death (RR 6.78, 95% CI 1.77-25.87, p <0.001). No significant differences in survival were observed based on the type of surgical approach (p = 0.428). ConclusionUncontrolled diabetes and DKA were the main predictors of mortality in patients with ROM, highlighting the critical role of metabolic management. Further studies with larger cohorts are needed to explore additional therapeutic strategies to improve survival outcomes. Author SummaryMucormycosis is a disease on the WHO priority list of fungal pathogens. It is associated with a high mortality rate, which has been reported to be as high as 80%. Diabetes mellitus is a common risk factor in mucormycosis cases. It is detected in 65%-85% of cases, especially in those with rhino-orbital mucormycosis (86.9%). It is considered a neglected disease that has increased disproportionately since the COVID-19 pandemic, although its prevalence is high, as in Iran and India. In Mexico, due to lack of knowledge among the population, it is a rare and neglected disease. We found that rhino-orbital mucormycosis, poor glycemic control and diabetic ketoacidosis were linked to higher mortality. Strict glucose control is essential. The type of surgical approach did not significantly affect the outcome. In order to refine interventions and better inform the future list of priority fungal pathogens, this study will provide robust estimates of disease burden and mortality.